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Abstract: The present study aimed at elucidating the effect of local pH in the extracellular microenvironment of 
tissue engineered (TE) constructs on bone cell functions pertinent to new tissue formation. To this aim, we evaluated 
the osteogenicity process associated with bone constructs prepared from human, bone marrow-derived stromal cells 
(hBMSC) combined with 45S5 bioactive glass (BG), a material that induces alkalinization of the external medium. 
The pH measured in cell-containing BG constructs was around 8.0, i.e., 0.5 unit more alkaline than that in two other 
cell-containing material (hydroxyapatite/tricalcium phosphate (HA/TCP) and coral) constructs tested. When 
implanted ectopically in mice, there was no de novo bone tissue in the BG cell-containing constructs, in contrast to 
results obtained with either HA/TCP or coral ceramics which consistently promoted formation of ectopic bone. In 
addition, the implanted 50:50 composites of both HA/TCP:BG and coral:BG constructs, that displayed a pH of 
around 7.8, promoted 20-30 fold less amount of bone tissue. Interestingly, hBMSC viability in BG constructs was 
not affected compared to the other two types of material constructs tested both in vitro and in vivo. Osteogenic 
differentiation (specifically, ALP activity and gene expression of RUNX2, ALP and BSP) was not affected when 
hBMSC were maintained in moderate alkaline pH (≤ 7.90) external milieu in vitro, but was dramatically inhibited at 
higher pH values. Formation of mineralized nodules in the extracellular matrix of hBMSC was fully inhibited at 
alkaline (> 7.54) pH values. Most importantly, there is a pH range (specifically, 7.9-8.27) at which hBMSC 
proliferation was not affected but the osteogenic differentiation of these cells was inhibited. Altogether, these 
findings provided evidence that excessive alkalinization in the microenvironment of TE constructs (resulting, for 
example, from material degradation) affects adversely the osteogenic differentiation of osteoprogenitor cells. 
Introduction:  
Bone marrow stromal cells (BMSC), which are able of 
osteodifferentiation and, thus, promote bone formation (1, 2), 
support the repair and/or regeneration of osseous defects when 
they are distributed in appropriate biomaterial scaffolds (3-6). Such 
scaffolds are designed as temporary matrices for supporting new 
tissue development and bone growth. The “ideal” scaffolds should 
provide a framework, as well as a specific environment, for cell 
attachment, proliferation, differentiation and formation of tissue-
specific extracellular matrix (ECM) (7). Such scaffolds should also 
be absorbable with rates of resorption that are commensurate to 
those of bone formation.  
Understanding, and controlling, pertinent cell functions by 
modulating the local engineered extracellular environment is a 
critical issue in the development of suitable material scaffolds for 
bone tissue engineering (TE) applications. In this respect, an 
extensive number of studies have reported the significant effect of 
scaffold properties, such as chemical composition, surface 
topography and chemistry, pore size, porosity, and specimen size 
on cell functions and, therefore, on the osteogenic outcome of 
engineered scaffolds (8, 9). However, the microenvironment or 
milieu where the cells reside has received little attention. This 
issue is even more critical because such local environments can be 
affected by the resorption of the scaffold material, especially by 
solutes arising from the material dissolution and by concomitant 
pH changes (10). 
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Among the biomaterials tested for bone TE application to date, 
calcium-based materials such as hydroxyapatite (HA), tricalcium 
phosphate (TCP), calcium carbonate (coral) ceramics and bioactive 
glass (BG) are the most promising ones. These calcium-containing 
materials are appropriate for bone-related applications because of 
similarities of their chemical and mechanical properties with the 
mineral phase of natural bone. In addition, these materials are 
considered osteoconductive and bioactive because of both their 
bonding capacity to surrounding osseous tissue and ability to 
promote new bone tissue formation (11, 12). When combined with 
human BMSC (hBMSC), HA, TCP, biphasic HA/TCP and coral 
ceramics induced de novo bone tissue in the subcutis of 
immunocompromised mice (13-15) (16-18). In contrast, and 
despite the expanding application of BG (such as 45S5 BG) and 
glass-ceramics as bone substitutes (19), information regarding the 
osteogenic potential of hBMSC in combination with BG scaffolds 
is strikingly lacking in the bone TE field. 
While the biocompatibility and osteoconductivity of BG has long 
been established (19, 20), such material is also known for the 
release of ion dissolution products as well as for inducing 
alkalinization of the external medium upon exposure to either 
physiological solutions or body fluids (21-23). Changes in the 
extracellular fluid pH of the local biological microenvironment can 
profoundly affect cell metabolism and function (22, 24) as well as 
the processes of bone tissue formation and mineralization (25). 
Chronic systemic acidosis promotes bone resorption, whereas 
alkalosis promotes bone formation by stimulating pertinent 
osteoblast functions (26-28). More recently, Shen et al. reported 
the beneficial role of local alkalinization mediated by borosilicate 
BG on the viability of preosteoblasts (10). However, the positive or 
negative effect of pH in cell constructs has never been investigated 
in the bone TE field. This aspect is crucial since the implanted 
hBMSC are in a confined space within tissue constructs and are, 
therefore, especially vulnerable to chemical changes within the 
local biological microenvironment.  
For these reasons, the present study focused on examining the 
impact of pH, specifically alkalinization, in the engineered 
extracellular microenvironment on hBMSC-mediated osteogenesis. 
To this aim, we evaluated both, in vitro and in vivo, the 
osteogenicity of bone constructs prepared from hBMSC combined 
with 45S5 BG (a material that induces alkalinization of the 
external medium) in comparison with results obtained using two 
other clinically-available, calcium-based scaffolds, specifically 
biphasic HA/TCP and coral ceramics. Biomaterial granules of 
equivalent size (~400 µm in diameter), similar construct 
preparation, and similar implant dimensions were used to ensure an 
equivalent material surface area (at the cell scale) as well as an 
equivalent inter-granule volume available to cells within 3D 
material constructs. The in vivo osteogenic outcomes of TE 
constructs were correlated with their local pH. In addition, the in 
vitro effect of pH on the proliferative and osteogenic 
differentiation of hBMSC was determined. 
Materials and Methods:  
Material scaffolds  
Three calcium-based materials in the form of granules were 
studied. These granules differed in terms of their chemical 
composition as well as shape and surface area but all had sizes in 
the 300-690 µm range. The biphasic calcium phosphate granules 
(HA/TCP), composed of 60% HA and 40% TCP, were produced 
using the spray drying process followed by high temperature 
calcination; these granules (300-570 µm; mean size: 417 µm) were 
donated by Zimmer, Inc (Saint-Priest, France). Natural coral 
granules (Porites species; Biocoral®) consisted of 99% calcium 
carbonate in the form of aragonite (29, 30); these materials (300-
600 µm; mean size: 426 µm) were donated by Inoteb, Inc. 
(Levallois-Perret, France). The non-porous 45S5 silicate BG 
(designated BG hereafter) granules of nominal 45% SiO2, 24.5% 
CaO, 24.5% Na2O and 6% P2O5 in wt%  composition (300-690 
µm; mean size: 457 µm) were donated by Noraker (Villeurbane, 
France) and were preconditioned in laboratory-made simulated 
body fluid (SBF) as recommended by the supplier. Briefly, BG 
granules were immersed in a SBF solution (0.1g of BG per mL of 
solution) and were maintained under mild stirring by rotation at 
37°C for 4 weeks. The SBF solution was renewed twice a week. 
Then, granules were rinsed with double distilled water and dried 
before sterilization. SBF pretreatment promotes the formation of a 
bone-like carbonated HA (cHA) layer as well as calcite on its 
surface (31-34). 
The surface of the granules used in the present study was examined 
using scanning electronic microscopy (SEM) (SEM-FEG, JEOL 
JSM-6500F, USA). The specific surface areas were determined 
according to the BET method 8 points using N2 adsorption 
isotherms (Micromeritics ASAP 2010) as previously described 
(35). The particle size distribution was determined by using a laser 
diffractometer with a Hydro 2000S module (Mastersizer 2000 from 
Malvern Instruments Ltd, UK). 
hBMSC isolation, expansion and labeling with Luc gene 
Human mesenchymal stem cells (hBMSC) were harvested from 
bone marrow obtained as discarded tissue (intramedullary 
reamings) from 4 female and 1 male patients 17, 31, 31, 49 and 63 
years old (mean age: 38.8 +/-17.7 years) who were operated for 
traumatic orthopedic indications in the absence of any detected 
chronic pathologies (such as diabetes, cancer, arthritis, etc…) at 
the Lariboisiere Hospital (Paris, France). The tissues were 
collected with the respective patient’s consent in agreement with 
Lariboisière Hospital (Paris, France) regulations. The hBMSC 
were isolated using a procedure adapted from literature reports (1). 
Briefly, cells were harvested by gently flushing the collected bone-
marrow samples through decreasing (from 16G to 21G) needle-
sizes. These cells were then cultured in standard cell culture 
medium, that is, alpha-modified Minimum Essential Medium 
(αMEM) containing 10% fetal calf serum (FCS; PAA 
Laboratories) and 1% of an antibiotic/anti-mycotic solution (PAA 
Laboratories), in a humidified, 37°C, 5% CO2/95% air 
environment. When the hBMSC reached 60–70% confluence, they 
were trypsinized and subcultured at a density of 1,000-5,000 cells 
cm-2. HBMSC obtained from the 5 aforementioned patients were 
pooled at the same density, expanded, and used up to passage 4-5 
for the experiments described in the sections that follow. 
Genetically modified hBMSC were obtained following their 
transduction with a lentiviral vector encoding firefly luciferase 
(fLuc) (pTMLW-MND-Luc; Vector platform/ INSERM U876) as 
previously described (36). Transduced cells (designated as 
LuchBMSC hereafter) were expanded and used to monitor the 
hBMSC viability in cell-containing constructs both in vitro and in 
vivo. 
Preparation of cell-containing constructs 
For all cell-related experiments in the present study, aliquots of 40 
mg of granules of the materials tested were sterilized by 
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autoclaving, then sequentially rinsed twice in phosphate buffer 
saline (PBS), and also rinsed once in serum-free αMEM (Sigma-
Aldrich) cell culture medium. 
Aliquots of hBMSC (or  LuchBMSC when so specified) were 
delivered (suspended in 100 µl of standard cell culture medium) to 
each material granules tested; the final cell density was 106 cells 
per cell-containing construct for in vivo studies or 105 cells per 
construct for in vitro studies. Unseeded scaffolds served as 
controls. After 4 hours of incubation at 37°C, the supernatant was 
discarded and the granules were embedded in a fibrin gel 
(Tissucol®, Baxter) prepared by mixing 100 µl of fibrinogen (9 
mg ml-1), with 5 µl of thrombin (100 UI ml-1) as previously 
described (37). These cell-containing constructs were maintained 
in 2 ml of standard cell culture medium at 37°C overnight before 
use in experiments.  
In vivo studies 
Ten-week-old, female, nude mice were obtained from Janvier 
(Legenest-Saint-Isle, France) and handled according to the 
European Guidelines for Care and Use of Laboratory Animals 
(EEC Directives 86/609/CEE of 24.11.1986). All experimental 
animal procedures conducted in the present study were approved 
by the Ethics Committee on Animal Research of the 
Lariboisiere/Villemin, Paris, France. The hBMSC-containing 
constructs (n=7 per group for the HA/TCP, coral, and BG 
constructs; n=6 per group for both the HA/TCP-BG and coral-BG 
composite constructs) were subcutaneously implanted in mice as 
previously described (36). Briefly, each mouse was preoperatively 
given analgesics (0.4 mg of buprenorphine per kg animal weight; 
Axience), anesthetized by intra-peritoneal injection of 100 mg kg-1 
ketamine (Ketalar®; Virbach) and 10 mg kg-1 xylazine 
(Rompun® 2%; Bayer), and its skin was disinfected. Symmetrical 
incisions were made on the back of each mouse on both sides of 
the spine and subcutaneous pouches were created. The cell-
containing constructs to be tested were inserted into each pouch (4 
constructs per mouse). The soft tissues at the implantation sites 
were then closed with interrupted non-resorbable sutures. Eight 
weeks post-implantation, the animals were sacrificed via injection 
of lethal doses of pentobarbital (Dolethal®; Vetoquinol). At that 
time, the constructs were retrieved en-bloc and fixed in 10% (v/v) 
phosphate-buffered formalin before analysis as described in the 
next section. 
For monitoring the implanted cell survival in vivo, special cell-
containing constructs were prepared using LuchBMSC. Following 
implantation of these cell constructs, the mice were imaged twice a 
week during the 8-weeks post-implantation period as previously 
described (38). Briefly, the mice were anesthetized by inhaling 
isoflurane followed by local injection of 100 µl of D-luciferin (15 
mg ml-1 in PBS) at each implantation site. The animals were then 
imaged using a bioluminescence imaging system (Ivis Lumina II, 
Caliper Life Sciences, USA). Standard regions of interest (ROI) 
surrounding each implant were delineated on the bioluminescence 
images and the photon flux emitted by each construct was 
quantified using the Living Image 3.1 software (Caliper Life 
Science). To compare cell survival in each construct tested, photon 
fluxes were normalized with respect to the signal acquired at the 
beginning (day 1) of the respective in vivo experiment. 
Histology and immunohistochemistry 
Six out of 7 retrieved constructs for each material tested were 
processed for undecalcified histology. After fixation, the explanted 
samples were rinsed in water, dehydrated in ethanol, cleared in 
xylene, and embedded in methyl methacrylate as previously 
described (29). Each sample was then cut into either 6 or 7 sections 
(each 500 µm thick) using a diamond circular saw (Leica 1600, 
Leica). Each such specimen section was then grounded to a 
thickness of 100 µm and stained using Stevenel’s blue and Van 
Gieson Picrofuchsin red for subsequent histological analysis. Three 
non-adjacent sections from each specimen were selected for 
histomorphometrical analysis. Histological examination was 
performed using an optical microscope (Nikon Eclipse TE2000-U; 
Nikon France) equipped with a numeric camera (DXM1200F; 
Nikon). Bone was quantified using the NIS-Elements BR 2.30 
software (Nikon). The surface area of bone (stained in red) was 
measured in each specimen section and normalized over the whole 
surface area delineated around each section. 
The remaining seventh retrieved construct (from the HA/TCP, 
coral, and BG constructs groups) was fixed in 4% 
paraformaldehyde (pH 7.4) for 36 hours, decalcified in Decalcifier 
II (Surgipath) at 4°C for 48 hours, and embedded in paraffin. 
Sequential sections were processed for human beta-microglobulin 
(a membrane protein that enables tracking human cells) 
immunodetection. Briefly, tissue sections were pre-treated in a 
proteolytic enzyme solution (Dako, Glostrup, Denmark) at 37°C 
for 20 min. Cell membranes were permeabilized using 0.3% Triton 
X-100 for 15 min; the endogenous peroxidase activity was 
inhibited by addition of peroxidase block (Kit Envision+, Dako), 
and the non-specific binding sites were blocked using Protein 
Block (Dako). The tissue sections thus prepared were sequentially 
incubated in primary antibody, polyclonal rabbit anti-beta-2-
microglobulin (1/1000; Novocastra) for 1 hour, incubated with 
Labelled Polymer-HRP Anti-Rabbit antibody (Envision+ Kit, 
Dako K4011) for 30 min, and visualized using the DAB 
chromogen (Envision+ Kit, Dako K4011) for 5 min. 
 
In vitro hBMSC adhesion and proliferation onto material 
scaffolds 
Cell adhesion was assessed using SEM. Briefly, hBMSC were 
seeded onto granules (103 cells per mg of material granules) and 
cultured under standard cell culture conditions for 24 hours. At that 
time, the specimens were washed once with cacodylate 0.1M (pH 
7.4) and fixed in 2.5% glutaraldehyde (in cacodylate 0.1M; pH7.4) 
at 4°C for 1 hour. After two washings in cacodylate, the specimens 
were dehydrated in successively increasing concentrations of 
alcohol (from 30 to 100%). For SEM examination, the specimens 
of interest were treated in hexamethylsilazane baths (HMDS, Delta 
microscopy), dried over-night, and coated using a sputter coater 
equipped with a gold target (EMSCOPE SC 500, Elexience, 
Verrières le Buisson). These specimens were examined using a 505 
Philips SEM (FEI Company, Eindhoven) at 10 keV. 
Proliferation of hBMSC onto the material granules tested was 
monitored in vitro both in 2D (i.e., granules deposited on the 
bottom of a tissue culture polystyrene dish) and in 3D (i.e., 
granules dispersed within fibrin gel constructs). Cell proliferation 
in 2D conditions was determined by DNA quantification. 
Specifically, aliquots of 40 mg of material granules were 
transferred in each well of 48-well plates; hBMSC (3x104 cells) in 
standard cell culture medium were seeded. At different times of 
culture (specifically, at 0, 14, 21 and 28 days), cells were lysed 
using lysis buffer (1 mM MgCl2, 0.1M Na2CO3, 0.1M NaHCO3, 
0.1% Triton X100 (v/v); pH 10.2) and freezed/thawed three times 
(to disrupt the cell membranes). Cell DNA content was determined 
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using the CyQuant® cell proliferation assay kit (Molecular Probes) 
according to the manufacturer's instructions. Cell proliferation in 
the 3D constructs was assessed using bioluminescent imaging. For 
this purpose, the cell-constructs were prepared using LuchBMSC 
(105 cells per construct), transferred into 24 well-plates, and 
cultured in standard cell culture medium for the prescribed time 
periods (up to 28 days). The bioluminescent (BLI) signal from 
each cell-containing construct was determined non-destructively 3-
times a week by adding D-luciferin (at a final concentration of 300 
ng mL-1 PBS) into each cell-construct-containing well; BLI 
images were acquired using a bioluminescence imaging system. To 
compare the time course of cell proliferation in each construct 
tested, photon fluxes were normalized with respect to the signal 
acquired at the beginning (day 1) of the respective cell culture 
period. 
Determination of the osteogenic differentiation of hBMSC in 
vitro 
In order to assess the osteogenic differentiation of hBMSC 
cultured onto the material granules of interest to the present study, 
cells were seeded at a density of 3x103 cells cm-2 in each well of 
6-well plates in the presence of 40 mg of granules of each one of 
the three materials tested. These cells were cultured in “osteogenic 
medium”, that is standard cell culture medium containing 10-7 M 
dexamethasone, 150 μM ascorbic acid-2 phosphate and 2 mM β-
glycerophosphate (all chemicals from Sigma-Aldrich), for up to 28 
days. The supernatant medium was replaced every 2-3 days for the 
duration of the study. In order to assess the impact of the cell 
culture medium pH on the osteogenic differentiation of hBMSC, 
the cells (3x103 cells cm-2) were cultured in osteogenic medium 
buffered with 25 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) the pH adjusted at either 
7.47, 7.90, 8.27, 8.85 or 9.37, and cultured in a humidified, 37°C, 
atmospheric air environment (in the absence of supplementary 
CO2 inlet) for up to 28 days. Cells in culture medium buffered 
using the physiological CO2/HCO3 buffer system at pH 7.54 were 
the respective controls. In this experiment, the initial pH value 
(pHini) of the osteogenic culture medium (which was added fresh 
to the cells), and the final pH value (pHfin) of the supernatant cell 
culture medium (which was removed from the cells) were 
specifically checked at each culture medium change (i.e., every 2-3 
days) during the cell culture period.  
At the end of each prescribed cell culture period, the osteogenic 
differentiation of these cells was assessed by quantifying 
expression of a panel of osteoblastic markers (as described in the 
next section) as well as by determination of the activity of alkaline 
phosphatase (ALP) and mineralization. ALP activity was 
determined both by staining the cell cultures in situ using a 
commercially-available kit according to the manufacturer's 
(Sigma-Aldrich) instructions and by quantifying ALP activity in 
cell lysates as previously described (39). The presence of calcium-
containing deposits in the extracellular matrix was detected by 
staining the cells using the Alizarin red (AR) method. All these 
experiments were performed in triplicate and repeated at two 
separate times. 
 
Quantitative gene expression analysis by Real Time 
Polymerase Chain Reaction (q-PCR)  
Total ribonucleic acid (RNA) was extracted from hBMSC using 
the NucleoSpin RNA II kit (Macherey-Nagel, Düren, Germany). 
RNA concentration was measured using a NanoDrop ND-1000 
(LabTech, Ringmer, UK) spectrophotometer. One µg of extracted 
RNA was used as template for single-strand cDNA synthesis using 
the SuperScriptTM II Reverse transcriptase Kit (Invitrogen). Five 
µl of cDNA (diluted at a 1:20 ratio) were used to program 
amplifications through real-time PCR reactions using specific 
primers of genes encoding for runt-related transcription factor 2 
(RUNX2) (Hs00231692_m1), collagen type 1 α1 
(Col1a1)(Hs00164004_m1), osteopontin (OPN) 
(Hs00960942_m1), osteocalcin (OC) (Hs00609452_g1) and for 
bone sialoprotein (BSP) (Hs00173720_m1) (all from Applied 
Biosystems Inc.), combined with TaqMan Universal PCR Master 
Mix using the MyiQTM Single-Color Real-Time PCR 
thermocycler (Bio-Rad Laboratories) according to the protocol 
described previously (40). All samples, including specimens from 
experiments and standards (n=3 for each condition), were run in 
triplicate and in parallel. Data were analyzed using the iCycler IQ 
software (Biorad) and were compared by the ΔΔCt method. The 
results from hBMSC cultured onto the material granules tested in 
the present study were normalized to the amount of 18S transcript 
and were expressed relative to the results obtained from cells at 
day 0. The results from hBMSC cultured at different pH values 
were normalized to the amount of 18S transcript, and were 
expressed relative to the results obtained from hBMSC cultured in 
non-osteogenic medium for the same time period. 
pH in the 3D constructs 
In order to determine the pH in the core environment of the 
material constructs containing the tested granules (without cells), a 
microelectrode (PerpHecT®ROSS; Thermo Scientific) was 
inserted in the material granules before the fibrin gelation. After 
gelation, the constructs were maintained in 2 ml of a weakly 
buffered solution, specifically PBS (1 mM sodium phosphate at pH 
7.4) in order to minimize the buffering impact on the pH 
determination. The pH was monitored at room temperature for 24 
consecutive hours. The global pH of the constructs seeded with 
106 hBMSC was also determined before (day 0) and after 
implantation in mice for either 3 or 7 days. After animal sacrifice, 
the cell constructs were excised, chopped into small pieces and 
transferred in 1 ml of 1 mM PBS solution (pH 7.4). After mixing, 
the pH of each such solution was measured using a calibrated pH-
meter (Star Orion).  
Statistical analyses 
Numerical results were reported as mean +/- standard deviation. 
The nonparametric Mann-Whitney U-test was used to analyze data 
from two independent conditions. When comparing data of more 
than two conditions, the Kruskal-Wallis one-way analysis test was 
used. Quantitative data from in vivo BLI signals were analyzed 
using the two-way analysis of variance (ANOVA). For all 
analyses, differences were considered to be statistically significant 
at p< 0.05. 
Results 
Physical properties of the granule surfaces 
Visualization of the three materials tested using SEM enabled 
analysis of their macro- and microstructure (Fig. 1 A-F). The 
HA/TCP granules exhibited round shape and rough surface texture 
(Fig. 1 A). At higher magnification (Fig. 1 B), the round HA/TCP 
granules contained dense aggregates (1-10 µm) of round elemental 
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particles/grains of the 100 nm size. The shapeless aggregates, 
which formed agglomerates were lightly bonded in contrast to the 
elemental grains which were highly sintered (i.e., more strongly 
bonded). The coral granules had branching shapes (Fig. 1 C). At 
higher magnification (Fig. 1 D), the coral granules exhibited a 
rough and granular surface as that observed with HA/TCP 
granules. The main coral granules were composed of dense 
aggregates of small, round and acicular particles a few nanometers 
in size (Fig. 1 D). The coral appeared denser than the HA/TCP 
granules (Fig 1B). The BG granules, preconditioned with SBF, 
displayed sharp angular shapes (Fig. 1 E). At higher magnification 
(Fig. 1 F), the cHA layer coating the surface of the BG granules 
contained round aggregates ranging between 200 nm to 1 μm in 
diameter, which were composed of smaller particles of about 100 
nm in diameter. The specific surface area of the coral, HA/TCP 
and BG granules was 0.06 m²g−1, 0.33 m²g−1 and 1.09 m²g−1, 
respectively. Altogether, these observations indicated that, at the 
nanometer scale, the surface topography and roughness of the three 
materials tested were different, but at the hBMSC scale (20-50 
µm), they were similar. 
In vivo bone formation by hBMSC contained in the 
constructs tested 
De novo bone formation was assessed when hBMSC-containing 
constructs (prepared with either HA/TCP, coral, BG or composite 
of either HA/TCP:BG or Coral:BG) were implanted ectopically in 
a mouse model. After 8 weeks of subcutaneous implantation, there 
was no bone formation in conjunction with material scaffolds 
without cells; these scaffolds, however, were infiltrated with 
fibrous tissue (data not shown). At the same time point, new bone 
tissue was observed both in the hBMSC-containing HA/TCP and 
coral constructs as shown in the representative histology results 
from such explants (Fig. 2A). The osteogenic outcome of hBMSC 
contained within the tested coral- and HA/TCP- implants was 
similar and was characterized by high prevalence of bone 
formation and by similar amount of deposited new bone tissue 
(Fig. 2B). In contrast, no bone tissue was detected in any of the 
hBMSC-containing BG constructs (Fig. 2A and 2B). When 
hBMSC were contained within the 50:50 composites of either 
HA/TCP:BG or coral:BG constructs, newly-formed bone was 
found at the periphery of the constructs as well as consistently in 
contact with the coral and HA/TCP material surfaces. Very small 
amount of bone tissue (< 0.2 % compared to 4.2 and 3.8 % for 
HA/TCP and coral cell-containing constructs, respectively) was 
observed (Fig 2A) and the prevalence of bone formation was 
reduced (Fig 2B) in composite constructs. Altogether, the present 
results provided evidence that, in contrast to the HA/TCP and coral 
materials tested, hBMSC cultured on BG did not induce bone 
formation; moreover, the presence of BG in the composite 
constructs tested had a negative effect on osteogenesis. 
 Viability of hBMSC onto the materials tested 
The issue of potential toxicity of BG on hBMSC was addressed. 
For this purpose, adhesion and proliferation of hBMSC on the 
material granules was determined. SEM examination at 24 h 
confirmed that the hBMSC adhered and spread in a similar fashion 
onto the three substrates tested (Fig. 3A). Cell proliferation was 
determined when hBMSC were cultured onto granules of each one 
of the three materials tested that had been placed on the bottom of 
individual wells of tissue culture dishes (Fig. 3B). DNA 
quantification at different time points over a 4-week period of 
culture provided evidence that, under these conditions, hBMSC 
proliferation was similar for hBMSC cultured on the three 
materials tested as well as on tissue culture polystyrene (TCPS), 
the reference substrate (Fig. 3B). 
Cell viability was also assessed by determining hBMSC 
proliferation within 3D cell-containing constructs composed of 
either HA/TCP, coral, or BG granules embedded in fibrin gel (Fig. 
3C). Proliferation of hBMSC (previously labeled with the 
luciferase gene reporter) was monitored non-destructively in each 
construct using bioluminescence imaging. Similar profiles of 
LuchBMSC proliferation kinetics were observed for the three types 
of constructs of interest to the present study. Compared to the 
initial seeding, the number of cells increased by 2- to 3-fold after 
15 days of culture; the highest cell proliferation was observed in 
the BG constructs (3.4 fold at day 14; p<0.05 compared to the 
other two material constructs) (Fig. 3C). Furthermore, hBMSC 
survival was also assessed in vivo after subcutaneous implantation 
of the cell-containing constructs in nude mice for 2 months (Fig. 
3D). For the cases tested, the number of viable implanted cells 
decreased over this time period. The decrease in cell survival was 
significantly (p < 0.05) slower in the BG constructs compared to 
that obtained on the HA/TCP and coral ones up to 14 days post-
implantation. After that time point, a steady decrease in the 
luminescence signal from all implanted cell-containing constructs 
was observed (Fig. 3D). As a result, only 10 to 30% of the initial 
cell numbers remained for all constructs tested at 8 weeks post-
implantation. These results indicated loss of viable hBMSC, which 
occurred upon implantation independent of the type of material 
tested; more importantly, the implanted hBMSC did not die faster 
in the BG than in the other two material constructs.  
Immunostaining of human β-2-microglobulin enabled visualization 
of the hBMSC still present in sections of constructs explanted 8 
weeks post-implantation (Fig. 3E). Human β-2-microglobulin-
positive cells were detected at different locations in the tissue 
surrounding the granules, but were most frequently found on the 
material surface of all three types of constructs tested (Fig. 3E). 
These results confirmed the cytocompatibility of the three 
materials tested over the 8-weeks period of implantation. It should 
be noted that hBMSC were detected not only in fibroblastic 
connective tissue but also in newly-formed bone as well as around 
blood vessels in the HA/TCP- and coral-cell-containing constructs 
(data not shown). In contrast, positive-stained hBMSC were only 
detected in the fibroblastic connective tissue in the BG-cell-
containing constructs. Overall, cell spreading on the granules 
surfaces (Fig. 3A), cell proliferation in vitro (Fig. 3B-C), as well as 
the scaffold material cytocompatibility in vivo (Fig. 3 D-E) 
provided evidence that the observed absence of de novo bone 
formation in the hBMSC-containing BG constructs is not the result 
of lack of cytocompatibility of the BG material.  
Osteogenic differentiation of hBMSC cultured onto the 
materials tested 
Another aspect addressed in the present study was the potential for 
osteogenic differentiation of hBMSC cultured on BG granules as 
compared to results obtained on either the HA/TCP or coral 
substrates. For this purpose, the ALP activity of hBMSC cultured 
in osteogenic differentiation medium on the three material-
granules tested was assessed. ALP activity of hBMSC cultured on 
either HA/TCP- or coral-granules peaked at 14 days (Fig. 4A), 
indicating osteogenic differentiation of hBMSC on these materials. 
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HBMSC exhibited a significant (p< 0.05) greater ALP activity on 
HA/TCP and coral than on BG granules at 14 and 21 days of 
culture (Fig 4A). In addition, the ALP activity of hBMSC cultured 
on TCPS (reference substrate) was 3-, 3-, and 7-fold higher than 
that obtained when the cells were cultured onto the HA/TCP, coral 
and BG granules, respectively (data not shown). The results were 
confirmed by the enhanced positive ALP-staining of cells cultured 
on HA/TCP and on coral granules compared to BG ones for 14 and 
28 days (Fig. 4B).  
A panel of genes indicative of osteogenic differentiation was also 
investigated using qPCR (Supplementary Fig 1). Expressions of all 
markers (specifically, RUNX2, Osterix, Col1a1, OC and OPN) 
tested by hBMSC were similar when cultured on the three types of 
granules at both 7 and 14 days of culture.  
Determination of the pH in the material constructs tested 
The pH in the core environment of the cell-free BG constructs was 
determined to assess the alkalinization induced by the material 
itself (in the absence of cell-mediated acidosis). Starting from 7.4, 
the pH increased during the first hours post-gelation and reached a 
plateau at later (>10 h) times (Fig 5A). At 24 h post-gelation, the 
pH values in the HA/TCP-, coral- and BG-containing constructs 
were 8.6, 8.3 and 9.1 ±0.1, respectively. The pH of the BG 
constructs was 0.5 and 0.8 units more alkaline than the pH 
determined in the HA/TCP- and coral-constructs, respectively.  
Because these cell-free conditions did not reflect those of the cell-
containing constructs implanted in vivo, the pH of constructs 
seeded with 106 cells was also measured before their implantation 
(day 0) and immediately upon their removal from mice after 3 and 
7 days of implantation. The pH in the cell-containing BG 
constructs was 8.03 ±0.03 at day 0 and remained similar at the 
prescribed post-implantation time points (Fig. 5B). The pH value 
in these BG constructs was 0.4-0.5 unit more alkaline (p<0.05) 
than that measured in the other two types of cell-containing 
material constructs. The pH from both cell-containing 
HA/TCP:BG and coral:BG composite constructs that contained 
increasing ratios of BG was also measured in vitro. The data 
showed a strong correlation (r² = 0.88 and 0.99 for the 
HA/TCP:BG and the coral: BG composites, respectively) between 
the pH and the content of BG in the scaffolds of cell-containing 
constructs (Fig. 5C). Altogether, these results confirmed the 
alkalinization of the environment of the BG cell-containing 
constructs.  
Osteogenic differentiation of hBMSC as a function of the pH 
of the cell culture medium  
The effect of the pH of the cell culture medium (ranging from 7.47 
to 9.37 using HEPES buffer) on both the proliferation and the 
osteoblastic differentiation potential of hBMSC was also 
investigated. It is worth to note that a decrease of both pHini and 
pHfin values ranging from 0.1 unit of pH, for the lowest pHini 
(7.47), to 0.8 unit for the highest pHini (9.37) value was noticed 
after 2-3 days of cell culture (Table in Fig. 6D). 
Under these conditions, DNA quantification provided evidence 
that hBMSC proliferation was unaffected at alkaline pH up to 8.27; 
there was no cell proliferation at pH 8.85 and the cells died at pH 
9.37 (Fig. 6A). In order to assess the impact of the medium pH on 
the osteoblastic differentiation potential of hBMSC, a panel of 
genes indicative of osteogenic differentiation was investigated 
using qPCR (Fig. 6B). hBMSC were cultured in non-osteogenic 
medium as negative control. At either physiological pHini (7.47) 
or moderate alkaline pHini (≤ 7.90), expression of the osteoblastic 
(RUNX2, ALP and BSP) markers was higher when the cells were 
cultured in osteogenic than in non-osteogenic media indicating 
osteogenic differentiation of the hBMSC in the range of these pH 
values (7.47 ≤ pHini ≤ 7.90). At higher (> 7.90)  pHini, gene 
expression of the three markers monitored dramatically decreased 
and reached similar, or even lower, levels of expression as the ones 
obtained when the cells were cultured in non-osteogenic medium. 
The extent of both the ALP activity and mineralization of the 
hBMSC extracellular matrix were also strongly dependent on the 
pH of the cell culture medium (Figs. 6C and 6D). The highest level 
of ALP activity occurred at day 14 when the cells were cultured at 
pHini 7.47 (Fig. 6C). Similar results were obtained when the cell 
culture medium was buffered (using a CO2/HCO3 system) either 
at pHini 7.54 or at a moderate alkaline pHini (7.90) level (Fig. 6C). 
At pHini 8.27, the ALP activity significantly decreased while at 
pHini 8.85, minimal ALP production occurred at a later time, 
specifically, at 28 days of culture (Fig. 6C). ALP staining of cells 
confirmed these results (Fig. 6D). Mineralization of the hBMSC 
extracellular matrix occurred only at physiologic pHini (pHini < 
7.54) and was visualized using Alizarin red staining (Fig. 6D). It is 
worth to note, however, that the cell culture medium buffered with 
HEPES affected the mineralization process; at similar pHini, the 
kinetics of mineral accumulation was delayed and the amount of 
mineral deposited was lower in the HEPES-buffered system 
compared to the results obtained using CO2/HCO3 system (Fig. 
6D).  
These results provided evidence that the alkaline pH (specifically 
pH > 7.9) affected adversely both the hBMSC osteogenic 
differentiation and, more strongly, the mineralization process of 
the extracellular matrix. Interestingly, while hBMSC proliferation 
(Fig. 6A) was not affected at pH 8.27 (the pH value in the vicinity 
of the BG granules in the cell constructs tested), their osteogenic 
differentiation was inhibited (Fig 6B-C). 
Discussion:  
The present study is the first to address the impact of pH in the 
microenvironment of bone TE constructs on osteogenesis. The 
results provided evidence that constructs of hBMSC contained in a 
material, specifically, BG, that induces alkalinization of the 
microenvironment did not promote de novo bone formation; in 
contrast, cell-containing constructs prepared with either HA/TCP 
or coral, the two other materials tested, which did not change 
significantly the microenvironment pH but consistently induced 
bone tissue.  
BG is well known to alkalinize surrounding fluids (22, 23) due to 
the consumption of protons (H3O+ ions) during the ion exchange 
reactions between the glass network and the aqueous media (41). 
In the present study, the pH within the cell-free BG constructs was 
around 9.0, and decreased to 8.0 in the cell-containing BG 
constructs both prior and after implantation in mice. This decrease 
in pH value, albeit without reaching the physiological value (7.4), 
is explained by the acidosis that accompanies cell metabolism. In 
addition, the strong correlation established between the pH and the 
proportion (in weight) of BG granules within the cell-containing 
composite constructs confirmed the effect of BG material in the 
alkalization process. 
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The hBMSC-mediated osteogenic potential was assessed in vivo 
after subcutaneous implantation of the cell-containing material 
constructs in mice. This is a standard in vivo model that excludes 
and/or reduces the effects of endogenous bone-forming cells and of 
bone-stimulating mechanotransduction on the process of new bone 
formation (13, 42). Interestingly, the in vivo results evidenced that 
the implanted 50:50 composites of both HA/TCP:BG and coral:BG 
constructs, whose pH was around 7.8, had very little amount of 
bone tissue after 8 weeks post-implantation. Altogether, these 
results evidenced a correlation between loss of the bone forming 
potential of the cell-containing constructs and the degree of 
alkalinization within these constructs: osteogenesis decreased 20-
30 fold when the pH rose from 7.5 to 7.8, and it was totally 
inhibited when the pH reached 8. 
BG and glass–ceramics are widely used in bone repair applications 
and are considered appropriate materials for bone TE applications 
(43). However, information regarding the performance of BG as 
scaffolds for the delivery of osteocompetent cells in TE 
applications has been lacking. The absence of osteoinductivity 
observed with BG-containing constructs in the present study is in 
agreement with the results from other groups who reported that 
various formulations of silicate glasses (such as 45S5 BG, 13-93 
BG and BG/polymer composites) seeded with stem/precursor cells 
promoted abundant fibrous tissue infiltration upon implantation in 
ectopic sites in rodents. These studies reported the presence of 
sporadic osteoid or bone-like tissue within constructs but none of 
them evidenced bone tissue formation unequivocally (44-46).  
In the present study, histological analysis of the composite 
constructs tested showed that the bone tissue was located onto the 
surface of either HA/TCP or coral, but not on BG. Such 
observation suggests that the reduced osteogenic potential in BG-
containing constructs in vivo was closely related to the BG 
material surface and/or to its local microenvironment. 
In respect to the physical properties of the material surface, the 
SEM images showed that, at the scale of hBMSC, i.e., 20-50 µm, 
the topography, roughness and available material surface for cell 
attachment was equivalent for the three materials tested. In respect 
to the material microenvironment, it is well-documented that 
dissolution of BG material mediates the release of ions such as 
Na+, Ca2+ and Si products (presumably in the form of silicic acid 
Si(OH)4) into the surrounding aqueous media; continuous 
hydrolysis of silica groups results in increased local pH (19). 
The impact of both material surface physico-chemistry and 
dissolution products (released in the microenvironment) on the 
hBMSC cytocompatibility was evaluated in vitro and in vivo. In 
vitro, both adhesion and proliferation of hBMSC cultured directly 
onto the BG surface were not affected compared to the other 
materials tested. When hBMSC were seeded within 3D BG 
constructs, and, therefore, exposed locally to this material 
dissolution products, cell viability was even higher compared to 
respective results obtained from the other two types of material 
constructs tested both in vitro and in vivo. Implanted hBMSC still 
remained on the surface of all types of materials tested 8 weeks 
post-implantation.  
Among the hypotheses that could explain the observed higher 
viability of hBMSC in BG constructs is the possible impact of BG 
on the metabolic activity of cells. Indeed, Silver et al. reported that 
BG enhanced glycolysis in osteoblasts in vitro and, thus, their 
cellular ATP production; those authors stated that these metabolic 
effects are most likely consequences of external and internal 
alkalinization in the cell milieu (22). If BG has similar effects on 
the hBMSC metabolism in vivo, as it does on osteoblasts in vitro 
(22), stimulation of ATP generation may be beneficial for cell 
viability inside the TE constructs tested. All in all, these data 
confirmed that BG materials are cytocompatible both in vitro and 
in vivo in agreement with previous studies (47, 48).  
On one hand, viability of hBMSC was not affected by BG, on the 
other hand, however, its potential for osteogenic differentiation 
was diminished in vitro. Such result obtained in vitro, as well as 
lack of osteogenic evidence in the cell-containing BG constructs in 
vivo, seems to be affected by the ionic exchange occurring at the 
surface of the material and/or by its side effects (such as pH 
changes). This hypothesis is strengthened by the minimal bone 
formation obtained from the 50:50 composites of both 
HA/TCP:BG and coral:BG constructs: osteogenesis decreased 20 – 
30-fold when half (in weight) of either the HA/TCP or coral 
granules was replaced by BG granules; this result suggests that one 
or several diffusible chemicals, such as ion complexes 
(concomitant to pH changes), impede the hBMSC-mediated 
osteogenesis.  
The aforementioned results are in striking contrast with the 
numerous literature reports regarding the beneficial effects of 
products released from BG (without taking into account 
concomitant pH changes) on various functions (such as 
proliferation, differentiation, extracellular matrix production, 
mineralization and even angiogenesis) of human progenitors 
pertinent to new tissue formation (49-52). Especially, Si-products 
were reported to enhance osteogenic markers in osteoprogenitor 
cells (53, 54). Nevertheless, within the microenvironment of the 
BG constructs in vivo, cells may have been exposed locally to 
higher concentrations of Si-products in the present study than those 
used in the published studies. Thus, one cannot exclude that release 
of ions/species (such as Na+, Ca2+ or more particularly Si(OH)4) 
from the BG granules into their microenvironment in the present 
study, may have contributed to the inhibition of bone tissue 
formation in vivo.  
The release of Si products from the BG material and the 
subsequent alkalinization of the surrounding medium are two 
chemical events that could not be separated in the present study 
because they are closely interlinked (19). However, the observed 
considerable (0.5 unit) rise in the pH of the BG constructs 
(compared to the other two types of material constructs tested) 
raised questions regarding how the biological, in particular 
osteogenic, responses of hBMSC were affected in an alkaline 
milieu. It should be noted that alkalinization of the external 
medium was likely accompanied by a shift in the intracellular pH 
(pHint) in the same direction. However, the magnitude of change 
in the pHint is usually smaller than that in the external/extracellular 
pH (pHext) because of the control mechanisms (such as ion-
transport systems) in eukaryotic cells (22, 55).  
The present results provided evidence that the in vitro hBMSC 
proliferation and osteogenic differentiation were not significantly 
affected at moderate alkaline pHext (up to 7.90) but were 
dramatically inhibited when the pHext increased further. 
Formation of mineralized nodules in the extracellular matrix of 
hBMSC proved more sensitive to the pHext since it was fully 
inhibited at alkaline (> 7.54) pHext values. Most importantly, these 
findings indicated that there is a pHext range (specifically, 7.9-
8.27) at which hBMSC proliferation was not affected but the 
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osteogenic differentiation of these cells was inhibited. Such pHext 
range encompassed the one determined in the cell-containing BG 
granules (pHext ~8) and could explain the observed proliferation 
of hBMSC in BG constructs in vitro and the cell viability in vivo 
but also, the absence of bone tissue formation in vivo.  
The effect of the pH of the tissue microenvironment on bone 
mineralization and repair has been reported previously (56-58). 
During the early healing phase in bone, Chakkalakal et al. 
determined that the tissue pH was lower than the physiologic (7.4) 
pH; when, subsequently this pH increased to more alkaline values 
(specifically, to pH 7.56), it was accompanied by mineral 
deposition (25). On a cellular level, during metabolic acidosis, 
osteoblast functions decline whereas during metabolic alkalosis 
osteoblast functions (specifically, cell viability, ALP activity and 
mineral deposition) increase (10, 26-28). With respect to bone TE 
using hBMSC, Kohn et al. reported that short-term (specifically, 
48 h) exposure of hBMSC at decreasing (specifically, from 7.8 to 
≤ 6.5) pH led to decrease of osteogenic phenotype markers, 
specifically, ALP activity and collagen synthesis (59). Some of the 
aforementioned studies, however, reported decrease of the 
osteoblastic activity at pH around 7.8 (27, 60), but have not tested 
a pH range that encompasses the excessive alkalosis (pH~8) 
observed in the microenvironment of the cell-containing BG 
constructs tested in the present study. Therefore, it is possible that 
the high local alkalinization induced by the BG constructs had 
adverse effects on the osteogenic differentiation of stem cells in 
contrast to the beneficial effects obtained with moderate alkalosis; 
in fact, such a condition was deleterious to hBMSC metabolism 
and function in vitro and, therefore, likely to their bone-formation 
ability in vivo.  
In conclusion, the results of the present study evidenced a close 
relationship between inhibition of the hBMSC-mediated 
osteogenesis observed in vivo and the local alkalinization within 
the TE constructs tested. Excessive alkalinization in the TE 
construct microenvironment (resulting, for example, from material 
degradation) affected adversely the osteogenic differentiation of 
osteoprogenitor cells and may have consequently inhibited the 
osteogenicity of the constructs in vivo. Thorough characterization 
and control of the local, engineered, extracellular environment 
(specifically, changes of pH) are critical issues, which must be 
addressed in the development of bioactive scaffolds for successful 
TE, bone-related applications.  
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Scanning electron micrographs of HA/TCP (A-B), coral (C-D) and BG (E-F) granules at low (A-C-E) and high (B-D-F) 
magnification. 
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Ectopic bone formation after 8 weeks of subcutaneous implantation of scaffolds containing hBMSC. (A) Representative, 
undecalcified, histological cross-sections of hBMSC-containing constructs composed of either HA/TCP, coral, BG granules 
or composites of either HA/TCP:BG or coral: BG (50:50 w/w). Stains: Stevenel’s blue and Van Gieson Picrofuchsin red. (B) 
Amount of new bone tissue determined by histomorphometric analysis. The frequency of bone formation per implant 
material tested is also indicated. (*) material scaffold; the red color provided evidence for mineralized bone tissue. 
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Viability of hBMSC onto material scaffolds either cultured in vitro (A-C) or implanted in vivo in nude mice (D-E). (A) In vitro 
hBMSC adhesion evaluated by SEM 24h post-cell-seeding. (B) In vitro cell proliferation assessed when hBMSC were cultured 
either directly on tissue culture polystyrene (TCPS; TPP®) alone or onto granules placed on the bottom of individual wells of 
TCPS dishes and determined by DNA quantification; (C) In vitro cell proliferation assessed when LuchBMSC were cultured 
within 3D constructs (composed of material granules embedded in fibrin gel) and determined by BLI monitoring. Photon 
fluxes (normalized to those obtained at day 1 after cell seeding) were plotted versus the number of days of cell culture. p< 
0.001 (two-ways analysis of variance) ; (#) p<0.05 for the BG constructs compared to the other two material constructs tested 
(Mann–Whitney test). (D) In vivo cell viability was determined by monitoring BLI over 58 days of implantation: Photon fluxes 
(normalized to those obtained at day 1 post-implantation) were plotted versus duration of implantation; p< 0.001 (two-ways 
analysis of variance); (#) p<0.05 (Mann–Whitney test) for the BG constructs compared to the other two material constructs. 
(E) hBMSC, still present in the constructs explanted 2 months post-implantation, were detected on paraffin-treated sections 
following immunostaining against human β-2-microglobulin. (*) scaffold material (either HA/TCP, coral or BG); (black arrow 
head) cells stained positive for human β-2-microglobulin.. 
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Osteogenic differentiation of hBMSC cultured onto granules of HA/TCP, coral and BG. (A) Kinetics of the ALP activity 
expressed by hBMSC; p < 0.001 (two-ways analysis of variance) and (#) p <0.05 (Mann–Whitney test) compared to values 
obtained with either HA/TCP or coral granules at the same time point. (B) hBMSC stained in situ for ALP after 0, 14 and 28 
days of cell culture. 
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pH determination within the material 
constructs. (A) Time-course of pH values 
at the core of the material granule 
constructs (without cells) using a 
microelectrode inserted before fibrin 
gelation. (B) pH measurements from cell 
constructs before (day 0) and after in 
vivo subcutaneous implantation for 
either 3 or 7 days. (C) In vitro pH 
determination as a function of the ratio 
(from 0 to 100 % in weight) of BG 
granules in either HA/TCP: BG or coral: 
BG cell-containing composite constructs. 
(#) p<0.05 (Mann–Whitney test) 
compared to values obtained with 
either HA/TCP or coral materials at the 
same time point. 
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Osteogenic differentiation of hBMSC as a function of the pH of the culture medium. (A) Proliferation of hBMSC cultured 
in buffered osteogenic medium either using a standard CO2/HCO3 system or adjusted to increasing alkaline pH values 
using 25 mM HEPES; p< 0.001 (two-way ANOVA) for the cell cultures at either pH 8.85 or 9.37; these results were 
compared to those obtained from cell cultures at other pH values (specifically, 7.47, 7.54, 7.90 and 8.27). (B) Gene 
expression of RUNX2, ALP and BSP by hBMSC cultured in osteogenic medium (Os+); gene expression was normalized first 
to that of the respective 18S (internal standard), and then to results obtained when cells were cultured in the non-
osteogenic culture medium (Os-); (a) p<0.05 compared to pH 7.47 Os+ group; (b) p<0.05 compared to pH 7.90 Os+ group; 
(c) p<0.05 compared to pH 8.27 Os+ group (Mann-Whitney tests). (C) Kinetics of the ALP activity expressed by hBMSC 
cultured in osteogenic medium; p< 0.001 (two-way ANOVA) for the cell cultures performed at either pH 8.27 or 8.85 
compared to cultures at other pH (specifically, 7.47, 7.54 and 7.90). (D) ALP and Alizarin Red (AR) in situ stainings of 
hBMSC. Average values of both the initial and final pH of the supernatant culture medium which were determined at each 
medium change during the course of the experiment are indicated in the Table included on this frame. 
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Supplementary Figure 1: Osteogenic gene expression by hBMSC cultured directly onto material granules in osteogenic 
medium for 7 (A) and 14 (B) days. Expression of the osteoblastic (RUNX2, Osterix, type 1 collagen (Col1a1), osteocalcin (OC) 
and osteopontin (OPN)) genes by these hBMSC was normalized first to that of the respective 18S (internal standard), and 
then to the respective gene expression results obtained from these cells at day 0.  
 
 
